BIOLIFE SOLUTIONS INC's ticker is BLFS and the CUSIP is 09062W204. A total of 110 filers reported holding BIOLIFE SOLUTIONS INC in Q3 2020. The put-call ratio across all filers is 0.18 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $4,020,156 | -37.4% | 291,105 | +0.2% | 0.00% | -100.0% |
Q2 2023 | $6,422,232 | -50.1% | 290,599 | -50.8% | 0.00% | 0.0% |
Q1 2023 | $12,858,242 | +140.5% | 591,184 | +101.3% | 0.00% | 0.0% |
Q4 2022 | $5,345,645 | -26.6% | 293,717 | -8.3% | 0.00% | 0.0% |
Q3 2022 | $7,286,000 | +46.8% | 320,227 | -10.9% | 0.00% | – |
Q2 2022 | $4,963,000 | -26.1% | 359,331 | +21.6% | 0.00% | -100.0% |
Q1 2022 | $6,717,000 | -53.8% | 295,496 | -24.3% | 0.00% | 0.0% |
Q4 2021 | $14,539,000 | +50.9% | 390,100 | +71.4% | 0.00% | 0.0% |
Q3 2021 | $9,632,000 | +1.5% | 227,600 | +6.8% | 0.00% | 0.0% |
Q2 2021 | $9,485,000 | +23.6% | 213,100 | 0.0% | 0.00% | 0.0% |
Q1 2021 | $7,672,000 | -10.8% | 213,100 | -1.2% | 0.00% | 0.0% |
Q4 2020 | $8,600,000 | +94.0% | 215,600 | +40.8% | 0.00% | – |
Q3 2020 | $4,432,000 | +77.7% | 153,150 | +2.1% | 0.00% | – |
Q3 2019 | $2,494,000 | -1.9% | 150,000 | 0.0% | 0.00% | – |
Q2 2019 | $2,543,000 | -5.3% | 150,000 | 0.0% | 0.00% | – |
Q1 2019 | $2,684,000 | – | 150,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Casdin Capital, LLC | 7,566,292 | $171,982,000 | 7.71% |
Gagnon Advisors, LLC | 205,968 | $4,682,000 | 2.16% |
Ranger Investment Management | 1,300,407 | $29,558,000 | 1.87% |
GAGNON SECURITIES LLC | 379,506 | $8,626,000 | 1.41% |
Zweig-DiMenna Associates LLC | 376,550 | $8,559,000 | 1.14% |
Meros Investment Management, LP | 48,504 | $1,102,000 | 0.87% |
Mesirow Financial Investment Management, Inc. | 10,526 | $239,000 | 0.81% |
Penbrook Management LLC | 48,615 | $1,105,000 | 0.72% |
MOODY ALDRICH PARTNERS LLC | 220,680 | $5,016,000 | 0.70% |
GENEVA CAPITAL MANAGEMENT LLC | 1,456,656 | $33,110,000 | 0.64% |